Introduction
Pasteurella multocida is a small gram-negative, saccharolytic, indole-positive, facultatively anaerobic cocco-bacillus. Carter's capsular serotype A is associated with several animal diseases of worldwide importance such as bovine and porcine pneumonia, fowl cholera and rabbit septicaemia. [1] [2] [3] Type A can be distinguished from other types4" by indirect haemagglutination (IHA) and hyaluronidase decapsulation (HYD). Similar organisms6 that do not produce indole and are unable to ferment mannitol and sorbitol have been designated Taxon 13. Many studies of the pathogenic mechanisms and immunogenicity of surface extracts of P. multocida serotypes have been made with the aim of developing vaccines. '-I However, effective vaccines have been developed only for types B and E, the haemorrhagic septicaemia serotypes. * Lugtenburg et a1. 13 ' l4 have shown a correlation between cell-envelope-protein type and pathogenicity of strains, presumably type D," isolated from swine atrophic rhinitis. For type A strains, an experimental vaccine for rabbits has been reported recently. It is based on a potassium thiocyanate extract of whole bacterial' and the protective immunogen has been identified as a 37.5-Kda outer membrane protein (OMP). l 7 The aim of this study was to analyse the OMP profiles of P. multocida type A and the related Taxon 13 strains isolated from bovine pneumonia, to determine the heterogeneity of this group, and to attempt to define a protective immunogen in a mouse septicaemia model, by investigation of the immunogenicity of the OMPs.
Materials and methods

Bacteria
With the exception of the reference strain NCTC 10322 which was obtained from the National Collection of Type Cultures, London NW9 5HT, all the strains were isolated at Veterinary Investigation Centres from the lungs of calves with pneumonia, and were identified M. Z. ABDULLAHI. N. J. L. GILMOUR AND I. R. POXTON provisionally as P . multocidu. 
Vaccine strains and preparation of vaccine
In a preliminary study,22 vaccine preparations from nine strains, containing capsule, lipopolysaccharide, formalin-killed bacteria or heat-killed bacteria, were tested for protective ability against homologous and heterologous challenge with 10 LD50 of live bacteria. The heat-killed cell vaccines of P . multocidu strains W674 and W829 afforded the best heterologous protection. These two strains, and a Taxon 13 strain (X120) which gave no protection, were selected for the present study.
Preparation of uuccine. Freeze-dried bacteria were plated on DSA and incubated overnight at 37°C in a moist sealed chamber to enhance hyaluronic acid production. 2 3 Several iridescent colonies, which represent the wild-type (virulent) phenotype, were inoculated into 30 ml of Brain Heart Infusion Broth (BHIB ; Oxoid) and incubated overnight at 37°C in an orbital shaker. The culture was transferred to 1 L of BHIB in a 2-L conical flask and kept for 6 h at 37°C in an orbital incubator. The cells were harvested by centrifugation at 12 000 Q for 20 min at 20°C, washed once in phosphate buffered saline pH 7.4 (PBS) and finally resuspended in 10 ml of PBS. They were killed in a water bath at 68°C for 90 min and, after sampling for sterility, they were freeze-dried. Vaccine consisted of dried bacteria (final concentration 5 mg/ml) in equal volumes of water and Bayol F (Esso) containing Arlacel (Sigma) 10%.
Immunisation and challenge of mice
Swiss white mice of both sexes, bred at MRI, were 4-6 weeks old at the beginning of an experiment. Groups of 10 mice were given two doses of 0.2 ml of vaccine subcutaneously, 14 days apart. Vaccinated mice and nonvaccinated controls were challenged intraperitoneally with 10 LD50 of a 6-h broth culture of the organism, 14 days after the second vaccination; and deaths were recorded up to 48 h after challenge. The LD50 was determined previously by the method of Reed and M~e n c h ;~~ it ranged from 7-5 x lo6 to 1-2 x lo8 organisms.
A 50-p1 sample of blood was collected from the tail vein of each mouse pre-vaccination and pre-challenge. The blood from each group was pooled, and the serum was stored at -20°C.
Isolation of outer membrane ( O M )
A modification of the method of Filip et a1., 25 for the preparation of OM from E. coli, was used. Confluent growth from each of five DSA plates was washed off with 5 ml of 0.01 M HEPES buffer, pH 7.4. The bacteria were deposited by centrifugation (20 000 g, 15 min), resuspended in 20ml of buffer, and disrupted in a French pressure cell (Aminco, Silver Springs, MD, USA) at 6000 psi. After removalofunbrokencells by centrifugation (1 0 000 g, 15 min), c. 400 pl of Sarkosyl (sodium N-lauroyl sarcosinate; Sigma; 30% w/v) was added to give a final concentration of 0.7%. The OM was deposited by centrifugation at 50 000 g for 1 h, washed in distilled water, resuspended in 1 ml of distilled water, and stored at -20°C.
SDS-PAGE and immunoblotting
OM proteins were analysed on slab gels 10% with Laemmli buffers,26 and stained with Coomassie Blue.
The method of Hancock and Poxton2' was used for immunoblotting. Separated proteins were transferred to nitrocellulose membranes (Sartorius, 0.2 pm pore-size), allowing transfer to proceed for 16 h at 12 V. For immunodetection by the BioRad system, the mouse sera were diluted 1 in 100, and the rabbit anti-mouse IgGhorseradish peroxidase conjugate (ICN Immunochemicals) was diluted 1 in 500. There were no features in the OMP patterns which allowed differentiation between the typical P . multocida and the Taxon 13 strains.
Results
SDS-PAGE of outer membrane protein (OMP)
Mouse protection
Groups of mice were vaccinated with heat-killed cells of strains W674 and W829 (P. multocida) and strain X 120 (Taxon 13). Vaccinated mice and nonvaccinated controls were challenged with 10 LD50 of the homologous strain and 16 heterologous strains representing most of the groups defined by SDS-PAGE of the OMPs (table 11) . Strain W674 appeared to afford the best protection-at least 50% protection against nine of the 17 challenge strains. Strain W829 gave this degree of protection against four strains, but the Taxon 13 strain X120 protected only against strain X9. Strain X120 was also the only strain that did not afford homologous protection at this level. There was no apparent correlation between the SDS-PAGE group pattern and protection.
Demonstration of antibody response to the major OMPs in vaccinated mice by immunoblotting
For each of the three groups of vaccinated mice, seven strains (against some of which vaccination was protective and some non-protective) were selected for investigation by immunoblotting with pre-vaccination and pre-challenge sera. With the pre-vaccination sera, immunoblots showed no reaction. In the pre-challenge sera, however, the mice had responded to at least two of the major OMPs; but there was no correlation between immunoblot pattern and protection. Proteins a and d were the most immunogenic. Immunoblots with pre-challenge sera from mice vaccinated with strain W829 are shown in fig. 2b . There was a relatively uniform response to both a and d proteins; but this did not depend upon the M, being the same as that of the vaccine strain. It appears that there are common epitopes on all the a proteins and similarly on all the d proteins. The response to the other two major proteins was much more variable and appeared to be PAGE-group specific, e.g., strains W829 and X1113 in tracks 1 and 3 of fig. 2 both belong to PAGE group 1 (table I). There was, however, no correlation between the patterns and protection : vaccine W829 protected against the strains in tracks 1, 2, 3 and 6, but not against the strains in tracks 4, 5 and 7, although the immunoblots in tracks 4 and 6 are indistinguishable.
Discussion
The patterns produced on SDS-PAGE by Sarkosyl extracts of P . multocida are similar to the patterns produced by the OMPs of other gramnegative bacteria, in which there are a small number of major proteins and several minor ones. 28 The four major proteins which we have labelled a-d have allowed us to arrange strains of P . multocida into groups (table I) . It is apparent from this grouping that strains of Taxon 13 share profiles of major OMPs with strains of P . multocida, and we suggest that these taxa cannot be distinguished on this basis. When mice were vaccinated with heat-killed cells they produced an antibody response to two or more of the major OMPs ( fig. 2b) . This response was a combination of species-specific and PAGEgroup-specific antibodies, but the latter did not correlate with protection. The proteins were antigenic in mice but not protective. Moreover, although proteins may differ from one another in M,, they did not necessarily differ antigenically. This finding applies also to other groups of closely related species, e.g., some of the major OMPs of Enterobacteriaceae share epitopes but differ in Mr. 29 Our conclusion is that, in this mouse model of pasteurellosis, the major OMPs are not protective antigens, and therefore may be unlikely candidates for vaccines. However, this appears to contradict the findings of Lu et al.17 who showed that the 37.5 Kda OMP (presumably our protein a) was protective against homologous challenge in a rabbit model; but in a mouse model, protection was afforded against heterologous challenge only if the challenge strain was shown, by probing with a monoclonal antibody, to express the 37-5-Kda antigen.30 Protection was not provided against strains lacking this antigen. Thus, they showed that this OMP can be a protective immunogen in the strains that possess it; but they concede that other antigens may be more important as vaccine candidates, because only 24% of their strains of P. multocida expressed this antigen.
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